Profile

KED Pharmaceuticals AG is a biopharmaceutical company specialized in marketing, sales and distribution of plasmaderivatives.

KED  Pharmaceuticals was founded in 2005 and is based in Vienna, Austria. We are a wholly-owned subsidiary of Kedrion S.p.A., based in Castelvecchio, Italy.

KED Pharmaceuticals exclusively distributes Kedrion products. We are active in the markets of the European Union (with the exception of Italy, Kedrion’s domestic market), in Switzerland, in the Middle East and in many Asian countries. Click here for more information.


Sponsorship of patient organisations 2011
Österreichische Selbsthilfegruppe für primäre Immundefekte (ÖSPID; www.oespid.at):
€ 4.000 (support of activities, congresses, organisational employments etc.)


More about Kedrion:

Kedrion is a biopharmaceutical company specialized in the development, production and distribution of plasma-derived products.

Born in 2001 of the rationalisation and upgrading of other companies that have been focusing on this challenging topic since the 1960s, Kedrion acquired a heritage of expertise that ensures it a prominent role in Italy, in Europe and in the world.

In Italy, Kedrion is a partner of the National Health Service for the production of plasma-derived medicinal products.

In addition, its expertise allows strategic partnerships with health institutions in other countries.

The company’s competitive edge relies on the quality of its products, its relentless commitment to research and development, its substantial industrial capacity, as well as on its established position on the domestic and international markets.

www.kedrion.com